Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity

Identifieur interne : 008B12 ( Main/Exploration ); précédent : 008B11; suivant : 008B13

Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity

Auteurs : Jeffrey D. Vassallo [États-Unis] ; Sarah M. Hicks [États-Unis] ; George P. Daston [États-Unis] ; Lois D. Lehman-Mckeeman [États-Unis]

Source :

RBID : ISTEX:6096A0F971509D612E5096EF326279325E011792

English descriptors

Abstract

Hepatotoxicity of coumarin is attributed to metabolic activation to an epoxide intermediate, coumarin 3,4-epoxide (CE). However, whereas rats are most susceptible to coumarin-induced hepatotoxicity, formation of CE is greatest in mouse liver microsomes, a species showing little evidence of hepatotoxicity. Therefore, the present work was designed to test the hypothesis that detoxification of CE is a major determinant of coumarin hepatotoxicity. CE can either rearrange spontaneously to o-hydroxyphenylacetaldehyde (o-HPA) or be conjugated with gluatathione (GSH). o-HPA is hepatotoxic and is further detoxified by oxidation to o-hydroxyphenylacetic acid (o-HPAA). In vitro experiments were conducted using mouse liver microsomes to generate a constant amount of CE, and cytosols from F344 rats, B6C3F1 mice, and human liver were used to characterize CE detoxification. All metabolites were quantified by HPLC methods with UV detection. In rats and mice, GSH conjugation occurred non-enzymatically and through glutathione-S-transferases (GSTs), and the kinetics of GSH conjugation were similar in rats and mice. In rat liver cytosol, oxidation of o-HPA to o-HPAA was characterized with a high affinity Km of approximately 12 μM, and a Vmax of approximately 1.5 nmol/min/mg protein. In contrast, the Km and Vmax for o-HPA oxidation in mouse liver cytosol were approximately 1.7 μM and 5 nmol/min/mg protein, respectively, yielding a total intrinsic clearance through oxidation to o-HPAA that was 20 times higher in mouse than in rats. Human cytosols (two separate pools) detoxified CE through o-HPA oxidation with an apparent Km of 0.84 μM and a Vmax of 5.7 nmol/min/mg protein, for a net intrinsic clearance that was more than 50 times higher than the rat. All species also reduced o-HPA to o-hydroxyphenylethanol (o-HPE), but this was only a major reaction in rats. In the presence of a metabolic reaction replete with all necessary cofactors, GSH conjugation accounted for nearly half of all CE metabolites in rat and mouse, whereas the GSH conjugate represented only 10% of the metabolites in human cytosol. In mouse, o-HPAA represented the major ring-opened metabolite, accounting for the remaining 50% of metabolites, and in human cytosol, o-HPAA was the major metabolite, representing nearly 90% of all CE metabolites. In contrast, no o-HPAA was detected in rats, whereas o-HPE represented a major metabolite. Collectively, these in vitro data implicate o-HPA detoxification through oxidation to o-HPAA as the major determinant of species differences in coumarin-induced hepatotoxicity.

Url:
DOI: 10.1093/toxsci/kfh162


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity</title>
<author>
<name sortKey="Vassallo, Jeffrey D" sort="Vassallo, Jeffrey D" uniqKey="Vassallo J" first="Jeffrey D." last="Vassallo">Jeffrey D. Vassallo</name>
</author>
<author>
<name sortKey="Hicks, Sarah M" sort="Hicks, Sarah M" uniqKey="Hicks S" first="Sarah M." last="Hicks">Sarah M. Hicks</name>
</author>
<author>
<name sortKey="Daston, George P" sort="Daston, George P" uniqKey="Daston G" first="George P." last="Daston">George P. Daston</name>
</author>
<author>
<name sortKey="Lehman Mckeeman, Lois D" sort="Lehman Mckeeman, Lois D" uniqKey="Lehman Mckeeman L" first="Lois D." last="Lehman-Mckeeman">Lois D. Lehman-Mckeeman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6096A0F971509D612E5096EF326279325E011792</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1093/toxsci/kfh162</idno>
<idno type="url">https://api.istex.fr/document/6096A0F971509D612E5096EF326279325E011792/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002D20</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002D20</idno>
<idno type="wicri:Area/Istex/Curation">002D20</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F99</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F99</idno>
<idno type="wicri:doubleKey">1096-6080:2004:Vassallo J:metabolic:detoxification:determines</idno>
<idno type="wicri:Area/Main/Merge">008D79</idno>
<idno type="wicri:Area/Main/Curation">008B12</idno>
<idno type="wicri:Area/Main/Exploration">008B12</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity</title>
<author>
<name sortKey="Vassallo, Jeffrey D" sort="Vassallo, Jeffrey D" uniqKey="Vassallo J" first="Jeffrey D." last="Vassallo">Jeffrey D. Vassallo</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Miami Valley Laboratories, The Procter and Gamble Company, 11810 East Miami River Road, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hicks, Sarah M" sort="Hicks, Sarah M" uniqKey="Hicks S" first="Sarah M." last="Hicks">Sarah M. Hicks</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>University of Wisconsin-Madison, Rennebohm Hall School of Pharmacy, 777 Highland Ave., Madison</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Miami Valley Laboratories, The Procter and Gamble Company, 11810 East Miami River Road, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Daston, George P" sort="Daston, George P" uniqKey="Daston G" first="George P." last="Daston">George P. Daston</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Miami Valley Laboratories, The Procter and Gamble Company, 11810 East Miami River Road, Cincinnati</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Miami Valley Laboratories, The Procter and Gamble Company, 11810 East Miami River Road, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lehman Mckeeman, Lois D" sort="Lehman Mckeeman, Lois D" uniqKey="Lehman Mckeeman L" first="Lois D." last="Lehman-Mckeeman">Lois D. Lehman-Mckeeman</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bristol-Myers Squibb Company, P.O. Box 4000, Princeton</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Miami Valley Laboratories, The Procter and Gamble Company, 11810 East Miami River Road, Cincinnati</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Toxicological Sciences</title>
<title level="j" type="abbrev">Toxicol. Sci.</title>
<idno type="ISSN">1096-6080</idno>
<idno type="eISSN">1096-0929</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2004-08">2004-08</date>
<biblScope unit="volume">80</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="249">249</biblScope>
<biblScope unit="page" to="257">257</biblScope>
</imprint>
<idno type="ISSN">1096-6080</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1096-6080</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>GSH conjugation</term>
<term>aldehyde dehydrogenase</term>
<term>coumarin</term>
<term>epoxide</term>
<term>hepatotoxicity</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Hepatotoxicity of coumarin is attributed to metabolic activation to an epoxide intermediate, coumarin 3,4-epoxide (CE). However, whereas rats are most susceptible to coumarin-induced hepatotoxicity, formation of CE is greatest in mouse liver microsomes, a species showing little evidence of hepatotoxicity. Therefore, the present work was designed to test the hypothesis that detoxification of CE is a major determinant of coumarin hepatotoxicity. CE can either rearrange spontaneously to o-hydroxyphenylacetaldehyde (o-HPA) or be conjugated with gluatathione (GSH). o-HPA is hepatotoxic and is further detoxified by oxidation to o-hydroxyphenylacetic acid (o-HPAA). In vitro experiments were conducted using mouse liver microsomes to generate a constant amount of CE, and cytosols from F344 rats, B6C3F1 mice, and human liver were used to characterize CE detoxification. All metabolites were quantified by HPLC methods with UV detection. In rats and mice, GSH conjugation occurred non-enzymatically and through glutathione-S-transferases (GSTs), and the kinetics of GSH conjugation were similar in rats and mice. In rat liver cytosol, oxidation of o-HPA to o-HPAA was characterized with a high affinity Km of approximately 12 μM, and a Vmax of approximately 1.5 nmol/min/mg protein. In contrast, the Km and Vmax for o-HPA oxidation in mouse liver cytosol were approximately 1.7 μM and 5 nmol/min/mg protein, respectively, yielding a total intrinsic clearance through oxidation to o-HPAA that was 20 times higher in mouse than in rats. Human cytosols (two separate pools) detoxified CE through o-HPA oxidation with an apparent Km of 0.84 μM and a Vmax of 5.7 nmol/min/mg protein, for a net intrinsic clearance that was more than 50 times higher than the rat. All species also reduced o-HPA to o-hydroxyphenylethanol (o-HPE), but this was only a major reaction in rats. In the presence of a metabolic reaction replete with all necessary cofactors, GSH conjugation accounted for nearly half of all CE metabolites in rat and mouse, whereas the GSH conjugate represented only 10% of the metabolites in human cytosol. In mouse, o-HPAA represented the major ring-opened metabolite, accounting for the remaining 50% of metabolites, and in human cytosol, o-HPAA was the major metabolite, representing nearly 90% of all CE metabolites. In contrast, no o-HPAA was detected in rats, whereas o-HPE represented a major metabolite. Collectively, these in vitro data implicate o-HPA detoxification through oxidation to o-HPAA as the major determinant of species differences in coumarin-induced hepatotoxicity.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>New Jersey</li>
<li>Ohio</li>
<li>Wisconsin</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Ohio">
<name sortKey="Vassallo, Jeffrey D" sort="Vassallo, Jeffrey D" uniqKey="Vassallo J" first="Jeffrey D." last="Vassallo">Jeffrey D. Vassallo</name>
</region>
<name sortKey="Daston, George P" sort="Daston, George P" uniqKey="Daston G" first="George P." last="Daston">George P. Daston</name>
<name sortKey="Daston, George P" sort="Daston, George P" uniqKey="Daston G" first="George P." last="Daston">George P. Daston</name>
<name sortKey="Hicks, Sarah M" sort="Hicks, Sarah M" uniqKey="Hicks S" first="Sarah M." last="Hicks">Sarah M. Hicks</name>
<name sortKey="Hicks, Sarah M" sort="Hicks, Sarah M" uniqKey="Hicks S" first="Sarah M." last="Hicks">Sarah M. Hicks</name>
<name sortKey="Lehman Mckeeman, Lois D" sort="Lehman Mckeeman, Lois D" uniqKey="Lehman Mckeeman L" first="Lois D." last="Lehman-Mckeeman">Lois D. Lehman-Mckeeman</name>
<name sortKey="Lehman Mckeeman, Lois D" sort="Lehman Mckeeman, Lois D" uniqKey="Lehman Mckeeman L" first="Lois D." last="Lehman-Mckeeman">Lois D. Lehman-Mckeeman</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008B12 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008B12 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6096A0F971509D612E5096EF326279325E011792
   |texte=   Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024